Botanical species · safety record

Betula alnoides

The EFSA Compendium of Botanicals holds 1 constituent measurement and 3 adverse-effect records for Betula alnoides. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Betula alnoides Buch.-Ham. ex D.Don

1Constituent measurements

3Safety records

3Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Methyl salicylate	Bark	Essential oil	99.4 Percent	—	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Bark	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive	Bark	Solvent extraction	—	In vitro	Resolve DOI
Reproductive	Testes	Bark	Solvent extraction	Rat (as animal)	Reproduction toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Ghimire, Bimal Kumar., Tamang, Jyoti Prakash., Yu, Chang Yeon., Jung, Suk Jun., Chung, Ill Min. Antioxidant, antimicrobial activity and inhibition of alpha-glucosidase activity by Betula alnoides Buch. bark extract and their relationship with polyphenolic compounds concentration. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2012, vol. 34, no. 5, p. 824-831. DOI
Wanichacheewa, S., Singtripop, T., Sassa, S., Sakamoto, S., Mori, T. Decrease in the number of sperm associated with decreased blood testosterone levels in male rats treated with extracts from seven plants consumed by natives of northern Thailand. Environmental Toxicology and Pharmacology, 2001, vol. 10, no. 1-2, p. 1-4. DOI
Nguyen, Xuan Dung., La, Dinh Moi., Leclercq, Piet A. Constituents of the bark oil of Betula alnoides Ham ex. D. Don from Vietnam. Journal of Essential Oil Research, 1995, vol. 7, no. 5, p. 565-566.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature